Operating Lease, Right-of-Use Asset of Milestone Pharmaceuticals Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Milestone Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Milestone Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $944,000, a 38% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Milestone Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $944,000 -$571,000 -38% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,090,000 -$561,000 -34% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,234,000 -$551,000 -31% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,376,000 -$541,000 -28% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $1,515,000 -$532,000 -26% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,651,000 -$524,000 -24% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,785,000 -$515,000 -22% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,917,000 -$506,000 -21% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $2,047,000 -$498,000 -20% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $2,175,000 +$1,605,000 +282% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,300,000 +$1,659,000 +259% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,423,000 +$1,712,000 +241% 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q3 2022 $2,545,000 +$1,765,000 +226% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $570,000 -$277,000 -33% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $641,000 -$273,000 -30% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $711,000 -$269,000 -27% 31 Dec 2021 10-K 21 Mar 2024 2023 FY
Q3 2021 $780,000 -$265,000 -25% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $847,000 +$470,000 +125% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $914,000 +$463,000 +103% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $980,000 +$456,000 +87% 31 Dec 2020 10-K 29 Mar 2023 2022 FY
Q3 2020 $1,045,000 +$452,000 +76% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $377,000 +$134,000 +55% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $451,000 +$169,000 +60% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $524,000 +$203,000 +63% 31 Dec 2019 10-K 24 Mar 2022 2021 FY
Q3 2019 $593,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $243,000 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $282,000 31 Mar 2019 10-Q 19 Jun 2019 2019 Q1
Q4 2018 $321,000 31 Dec 2018 10-K 29 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.